TherapeuticsMD (NASDAQ:TXMD) reported its Q1 earnings results on Monday, May 16, 2022 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
TherapeuticsMD missed estimated earnings by 18.0%, reporting an EPS of $-4.72 versus an estimate of $-4.0.
Revenue was down $533.00 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.01 which was followed by a 0.0% increase in the share price the next day.
Here’s a look at TherapeuticsMD’s past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.08 | -0.10 | -0.11 | -0.12 |
| EPS Actual | -0.09 | -0.11 | -0.11 | -0.11 |
| Revenue Estimate | 29.39M | 25.87M | 22.11M | 19.77M |
| Revenue Actual | 18.68M | 25.41M | 23.00M | 19.87M |
To track all earnings releases for TherapeuticsMD visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
